Cipla Ltd.
Snapshot View

View in App

Prices View details >>

1027.35 -11.05 ▼-1.1%

12 August 2022, 04:01:00 PM
Volume: 29,288

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.cipla.com
Market Cap 82,906.37 Cr.
Enterprise Value(EV) 81,802.03 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 30.84 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 33.32 Trailing Twelve Months Ending 2022-06
Industry PE 32.02 Trailing Twelve Months Ending 2022-06
Book Value / Share 266.47 Trailing Twelve Months Ending 2022-06
Price to Book Value 3.86 Calculated using Price: 1,027.35
Dividend Yield 0.49 Period Ending 2022-03
No. of Shares Subscribed 80.70 Cr. 806,992,476 Shares
FaceValue 2
Company Profile
The company is in the business of manufacturing, developing, and marketing wide range of branded and generic formulations and Active Pharmaceutical Ingredients (APIs). The company has its wide network of manufacturing, trading and other incidental operations in India and International markets.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-1.06%
1 Week
-0.67%
1 Month
+9.79%
3 Month
+11.54%
6 Month
+7.23%
1 Year
+13.51%
2 Year
+34.79%
5 Year
+89.30%
10 Year
+193.65%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 14.89 12.10 12.61 8.72 10.65 10.37 10.09 14.13 13.10
Return on Capital Employed (%) 19.05 15.33 13.24 8.28 10.20 11.94 12.53 17.85 17.24
Return on Assets (%) 10.49 7.85 7.28 4.97 6.52 6.50 6.56 9.95 9.94

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 9,019 10,050 10,801 11,516 12,544 14,229 15,012 15,763 18,327 20,842
Non Curr. Liab. 1,025 2,028 2,418 1,407 4,515 4,259 4,646 2,972 1,660 622
Curr. Liab. 2,278 2,564 3,881 7,776 3,389 3,832 3,772 4,393 4,591 4,913
Minority Int. 50 180 350 438 352 332 294 259 276
Equity & Liab. 12,321 14,692 17,281 21,049 20,886 22,673 23,762 23,423 24,837 26,652
Non Curr. Assets 5,537 9,040 9,689 12,208 12,082 11,859 11,335 11,717 11,656 11,941
Curr. Assets 6,784 5,652 7,591 8,841 8,804 10,814 12,427 11,706 13,181 14,711
Misc. Exp. not W/O
Total Assets 12,321 14,692 17,281 21,049 20,886 22,673 23,762 23,423 24,837 26,652

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 10,173 11,345 13,595 14,394 15,156 16,362 17,132 19,160 21,763 21,634
Other Income 265 166 208 229 358 477 369 270 322 319
Total Income 10,439 11,511 13,803 14,623 15,513 16,839 17,501 19,429 22,085 21,954
Total Expenditure -8,040 -9,184 -11,115 -11,919 -12,329 -13,265 -13,951 -14,911 -17,251 -17,284
PBIDT 2,398 2,327 2,688 2,704 3,184 3,574 3,550 4,518 4,834 4,670
Interest -146 -168 -207 -159 -114 -168 -197 -161 -106 -95
Depreciation -373 -505 -754 -1,323 -1,323 -1,326 -1,175 -1,068 -1,052 -1,045
Taxation -463 -400 -332 -180 -250 -570 -631 -889 -934 -918
Exceptional Items -78 -182 -58
PAT 1,417 1,254 1,395 1,042 1,419 1,510 1,547 2,401 2,559 2,554
Minority Interest -16 -48 -23 -29 -6 35 47 16 -30 -54
Share Associate -12 -25 -12 -7 -3 -17 -47 -13 -13 -11
Other Related Items
Consolidated Net Profit 1,388 1,181 1,360 1,006 1,411 1,528 1,547 2,405 2,517 2,488
Adjusted EPS 17 15 17 13 18 19 19 30 31 31

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 1,398 1,563 1,173 1,741 2,382 1,463 1,691 3,068 3,755 3,326
Cash Fr. Inv. -2,063 -1,250 -941 -4,523 -1,310 -854 -1,669 104 -2,387 -1,872
Cash Fr. Finan. 718 -266 165 3,104 -1,326 -385 -349 -2,949 -1,240 -1,600
Net Change 53 48 397 322 -254 223 -326 224 129 -146
Cash & Cash Eqvt 143 176 564 858 610 853 508 742 790 658

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 36.68 36.70 36.70 36.73 36.72 36.12 36.11 33.63 33.61
Public 63.32 63.30 63.30 63.27 63.28 63.88 63.89 66.37 66.39
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Thu, 04 Aug 2022
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that Registrar and Transfer Agent of Company M/s. KFin Technologies Limited has received intimation for loss of share certificate and request for issuance of duplicate share certificate from the shareholder.
Thu, 04 Aug 2022
Announcement under Regulation 30 (LODR)-Acquisition
Cipla (EU) Limited ("Cipla EU") wholly owned subsidiary of the Company in UK has agreed to acquire an additional 19.16% stake in Cipla Maroc SA joint venture and subsidiary of Cipla EU in Morocco.
Wed, 03 Aug 2022
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that Registrar and Transfer Agent of Company M/s. KFin Technologies Limited has received intimation for loss of share certificate and request for issuance of duplicate share certificate from the shareholder

Technical Scans View Details >>

Fri, 12 Aug 2022
Opening at High Opening at High
Closing Below Previous Low Closing Below Previous Low
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase 1 Month High Increase 1 Month
High Increase 3 Months High Increase 3 Months

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 219,167.25 913.45 -0.8%
Divi's Laboratories Ltd. 98,918.90 3,726.20 -5.6%
Dr. Reddy's Laboratories Ltd. 70,920.35 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. 62,010.73 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. 51,917.53 1,534.00 -0.1%
Piramal Enterprises Ltd. 45,855.65 1,921.35 +0.8%
Abbott India Ltd. 39,867.83 18,761.95 -1.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.35 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 33.43 3,726.20 -5.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.69 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 70.15 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 64.82 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-06 24.38 1,921.35 +0.8%
Abbott India Ltd. Standalone 2022-06 49.31 18,761.95 -1.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.37 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8.44 3,726.20 -5.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.50 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.43 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.12 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-06 1.28 1,921.35 +0.8%
Abbott India Ltd. Standalone 2022-06 13.37 18,761.95 -1.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,726.20 -5.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 1.56 1,921.35 +0.8%
Abbott India Ltd. Standalone 2022-03 0.00 18,761.95 -1.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,726.20 -5.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,921.35 +0.8%
Abbott India Ltd. Standalone 2022-03 29.95 18,761.95 -1.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,726.20 -5.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,921.35 +0.8%
Abbott India Ltd. Standalone 2022-03 29.95 18,761.95 -1.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,726.20 -5.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 13,993.30 1,921.35 +0.8%
Abbott India Ltd. Standalone 2022-03 4,919.27 18,761.95 -1.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,726.20 -5.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 1,345.89 1,921.35 +0.8%
Abbott India Ltd. Standalone 2022-03 798.70 18,761.95 -1.0%

FAQ's On Cipla Ltd.

Can I Buy Cipla Shares now?
What is the Share Price of Cipla?
What is the Relative Strength Index (RSI) Value of Cipla?
What is the Market Capital (MCAP) of Cipla?
What are the key metrics to analyse Cipla?
What is the Price Performance of Cipla?